Key issues in oncology appraisals, extrapolation of survival data, handling treatment crossover in oncology trials, a view from the Appraisal Committee. The sessions will highlight key methodological and practical issues involved in these appraisals and will set out the available methods for handling them. Recent developments will also be highlighted.
